1. Home
  2. HIO vs PGEN Comparison

HIO vs PGEN Comparison

Compare HIO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIO
  • PGEN
  • Stock Information
  • Founded
  • HIO 1993
  • PGEN 1998
  • Country
  • HIO United States
  • PGEN United States
  • Employees
  • HIO N/A
  • PGEN N/A
  • Industry
  • HIO Finance/Investors Services
  • PGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIO Finance
  • PGEN Health Care
  • Exchange
  • HIO Nasdaq
  • PGEN Nasdaq
  • Market Cap
  • HIO 369.0M
  • PGEN 404.4M
  • IPO Year
  • HIO N/A
  • PGEN N/A
  • Fundamental
  • Price
  • HIO $3.93
  • PGEN $1.45
  • Analyst Decision
  • HIO
  • PGEN Strong Buy
  • Analyst Count
  • HIO 0
  • PGEN 3
  • Target Price
  • HIO N/A
  • PGEN $6.00
  • AVG Volume (30 Days)
  • HIO 305.3K
  • PGEN 1.6M
  • Earning Date
  • HIO 01-01-0001
  • PGEN 08-13-2025
  • Dividend Yield
  • HIO 10.33%
  • PGEN N/A
  • EPS Growth
  • HIO N/A
  • PGEN N/A
  • EPS
  • HIO N/A
  • PGEN N/A
  • Revenue
  • HIO N/A
  • PGEN $4,201,000.00
  • Revenue This Year
  • HIO N/A
  • PGEN $158.57
  • Revenue Next Year
  • HIO N/A
  • PGEN $1,086.91
  • P/E Ratio
  • HIO N/A
  • PGEN N/A
  • Revenue Growth
  • HIO N/A
  • PGEN N/A
  • 52 Week Low
  • HIO $3.52
  • PGEN $0.65
  • 52 Week High
  • HIO $4.03
  • PGEN $2.17
  • Technical
  • Relative Strength Index (RSI)
  • HIO 61.98
  • PGEN 53.70
  • Support Level
  • HIO $3.79
  • PGEN $1.47
  • Resistance Level
  • HIO $3.92
  • PGEN $1.59
  • Average True Range (ATR)
  • HIO 0.03
  • PGEN 0.11
  • MACD
  • HIO 0.00
  • PGEN 0.01
  • Stochastic Oscillator
  • HIO 92.86
  • PGEN 63.64

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: